Fosby Bjarte, Melum Espen, Bjøro Kristian, Bennet William, Rasmussen Allan, Andersen Ina Marie, Castedal Maria, Olausson Michael, Wibeck Christina, Gotlieb Mette, Gjertsen Henrik, Toivonen Leena, Foss Stein, Makisalo Heikki, Nordin Arno, Sanengen Truls, Bergquist Annika, Larsson Marie E, Soderdahl Gunnar, Nowak Greg, Boberg Kirsten Muri, Isoniemi Helena, Keiding Susanne, Foss Aksel, Line Pål-Dag, Friman Styrbjörn, Schrumpf Erik, Ericzon Bo-Göran, Höckerstedt Krister, Karlsen Tom H
Section for Transplantation Surgery, Department of Transplantation Medicine, Division of Cancer, Surgery and Transplantation, Oslo University Hospital , Oslo , Norway.
Scand J Gastroenterol. 2015 Jun;50(6):797-808. doi: 10.3109/00365521.2015.1036359.
The Nordic Liver Transplant Registry (NLTR) accounts for all liver transplants performed in the Nordic countries since the start of the transplant program in 1982. Due to short waiting times, donor liver allocation has been made without considerations of the model of end-stage liver disease (MELD) score. We aimed to summarize key outcome measures and developments for the activity up to December 2013.
The registry is integrated with the operational waiting-list and liver allocation system of Scandiatransplant (www.scandiatransplant.org) and accounted at the end of 2013 for 6019 patients out of whom 5198 were transplanted. Data for recipient and donor characteristics and relevant end-points retransplantation and death are manually curated on an annual basis to allow for statistical analysis and the annual report.
Primary sclerosing cholangitis, acute hepatic failure, alcoholic liver disease, primary biliary cirrhosis and hepatocellular carcinoma are the five most frequent diagnoses (accounting for 15.3%, 10.8%, 10.6%, 9.3% and 9.0% of all transplants, respectively). Median waiting time for non-urgent liver transplantation during the last 10-year period was 39 days. Outcome has improved over time, and for patients transplanted during 2004-2013, overall one-, five- and 10-year survival rates were 91%, 80% and 71%, respectively. In an intention-to-treat analysis, corresponding numbers during the same time period were 87%, 75% and 66%, respectively.
The liver transplant program in the Nordic countries provides comparable outcomes to programs with a MELD-based donor liver allocation system. Unique features comprise the diagnostic spectrum, waiting times and the availability of an integrated waiting list and transplant registry (NLTR).
北欧肝脏移植登记处(NLTR)记录了自1982年移植项目启动以来北欧国家进行的所有肝脏移植情况。由于等待时间短,在进行供肝分配时未考虑终末期肝病模型(MELD)评分。我们旨在总结截至2013年12月该活动的关键结果指标和发展情况。
该登记处与斯堪的纳维亚移植组织(www.scandiatransplant.org)的运营等待名单和肝脏分配系统整合,在2013年底记录了6019名患者,其中5198名接受了移植。每年手动整理受者和供者特征以及再移植和死亡等相关终点的数据,以便进行统计分析和年度报告。
原发性硬化性胆管炎、急性肝衰竭、酒精性肝病、原发性胆汁性肝硬化和肝细胞癌是最常见的五种诊断(分别占所有移植的15.3%、10.8%、10.6%、9.3%和9.0%)。过去10年非紧急肝脏移植的中位等待时间为39天。随着时间推移结果有所改善,对于2004 - 2013年期间接受移植的患者,总体1年、5年和10年生存率分别为91%、80%和71%。在意向性分析中,同一时期相应数字分别为87%、75%和66%。
北欧国家的肝脏移植项目提供的结果与基于MELD的供肝分配系统的项目相当。独特之处包括诊断范围、等待时间以及综合等待名单和移植登记处(NLTR)的可用性。